Preemptive and therapeutic donor lymphocyte infusion for acute leukemia or myelodysplastic syndromes: a real-world single-center study.
BACKGROUND Allogeneic hematopoietic cell transplantation (HCT) remains a potentially curative therapy for a broad range of hematologic malignancies. Early attempts to reduce graftversus-host disease (GVHD), particularly through in vitro T-cell depletion, underscored the central role of donor immune cells in disease con...